Safety and Immunogenicity of a mRNA-based Chikungunya Vaccine in a Phase 1 Dose-Ranging Trial

International Journal of Infectious Diseases - Netherlands
doi 10.1016/j.ijid.2018.11.058
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

First-In-Human Phase 1 Trial of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 5 HVR48 (rAd5HVR48) HIV-1 Vaccine

Retrovirology
VirologyInfectious Diseases
2012English

Phase 1 Safety and Immunogenicity Trial of Recombinant Lactococcus Lactis Expressing Human Papillomavirus Type 16 E6 Oncoprotein Vaccine in Healthy Females

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2019English

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-Controlled, First-In-Human Phase 1 Trial

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Safety, Immunogenicity, and Lot-To-Lot Consistency of Live Attenuated Varicella Vaccine in 1-3 Years Old Children: A Double-Blind, Randomized Phase III Trial

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

Safety and Immunogenicity of a Live Attenuated Mumps Vaccine

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2014English

Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) in Adolescents and Adults: A Phase III Randomized Study

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2020English

An Escalating Dose Study to Assess the Safety, Tolerability and Immunogenicity of a Herpes Simplex Virus DNA Vaccine, COR-1

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2016English

Phase I Clinical Trial of an Intranodally Administered mRNA Based Therapeutic Vaccine Against HIV-1 Infection

AIDS
Infectious DiseasesAllergyImmunology
2018English

Safety and Immunogenicity of a Novel Staphylococcus Aureus Vaccine: Results From the First Study of the Vaccine Dose Range in Humans

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy